Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 2 |
2024 | 4 |
Search Results
5 results
Results by year
Filters applied: . Clear all
Page 1
Aspirin for Metabolic Dysfunction-Associated Steatotic Liver Disease Without Cirrhosis: A Randomized Clinical Trial.
JAMA. 2024 Mar 19;331(11):920-929. doi: 10.1001/jama.2024.1215.
JAMA. 2024.
PMID: 38502074
Clinical Trial.
Fibroblast growth factor inhibition by molecular-targeted agents mitigates immunosuppressive tissue microenvironment in hepatocellular carcinoma.
Suzuki H, Iwamoto H, Tanaka T, Sakaue T, Imamura Y, Masuda A, Nakamura T, Koga H, Hoshida Y, Kawaguchi T.
Suzuki H, et al.
Hepatol Int. 2024 Apr;18(2):610-622. doi: 10.1007/s12072-023-10603-z. Epub 2023 Oct 21.
Hepatol Int. 2024.
PMID: 37864726
Free PMC article.
Item in Clipboard
Primary liver cancer spectrum: current knowledge and the next steps.
Rezaee-Zavareh MS, Koltsova EK, Hoshida Y, Yang JD.
Rezaee-Zavareh MS, et al.
Hepatobiliary Surg Nutr. 2024 Feb 1;13(1):157-160. doi: 10.21037/hbsn-23-607. Epub 2024 Jan 15.
Hepatobiliary Surg Nutr. 2024.
PMID: 38322221
Free PMC article.
No abstract available.
Item in Clipboard
The phosphatidylserine targeting antibody bavituximab plus pembrolizumab in unresectable hepatocellular carcinoma: a phase 2 trial.
Hsiehchen D, Beg MS, Kainthla R, Lohrey J, Kazmi SM, Khosama L, Maxwell MC, Kline H, Katz C, Hassan A, Kubota N, Siglinsky E, Pillai AK, Youssoufian H, Mockbee C, Culm K, Uhlik M, Benjamin L, Brekken RA, Ahn C, Singal AG, Zhu H, Hoshida Y, Yopp AC.
Hsiehchen D, et al.
Nat Commun. 2024 Mar 11;15(1):2178. doi: 10.1038/s41467-024-46542-y.
Nat Commun. 2024.
PMID: 38467639
Free PMC article.
Clinical Trial.
Item in Clipboard
Disseminative Recurrence Signature for Hepatocellular Carcinoma From Nonalcoholic Fatty Liver Disease.
Fujiwara N, Kubota N, Zhu S, Nakagawa S, Baba H, Hoshida Y.
Fujiwara N, et al.
Gastro Hep Adv. 2023;2(5):681-683. doi: 10.1016/j.gastha.2023.03.021. Epub 2023 Mar 20.
Gastro Hep Adv. 2023.
PMID: 37621719
Free PMC article.
No abstract available.
Item in Clipboard
Cite
Cite